CareCloud announces new RCM agreements, leveraging acquisitions and AI to enhance customer relationships and drive recurring revenue growth.
Quiver AI Summary
CareCloud, Inc. has announced the signing of several new full-service revenue cycle management (RCM) agreements, showcasing the success of its strategy that combines acquisitions, AI innovations, and cross-selling to generate recurring revenue opportunities. The company, which specializes in AI-powered healthcare technology, has achieved a significant reduction in claim denials and aims to leverage existing customer relationships to drive growth. CEO Stephen Snyder emphasized that their approach allows for additional business generation from current clients while fostering a scalable business model. The new agreements, which involve three existing SaaS customers expanding their use of CareCloud’s services, follow four previously announced RCM contracts and highlight the potential for increased adoption of CareCloud’s solutions among its more than 40,000 provider base. The overall goal remains to enhance operational efficiency and long-term shareholder value through innovative, technology-driven healthcare solutions.
Potential Positives
- CareCloud has successfully formed multiple new full-service RCM agreements, showcasing the effectiveness of its acquisition-driven cross-selling strategy.
- The company has achieved over a 40% reduction in claim denials over the past year, indicating improved operational performance.
- CareCloud's growth strategy is supported by a customer base of more than 40,000 providers, presenting significant recurring revenue opportunities across its service offerings.
- The company's emphasis on AI-driven solutions reflects a commitment to enhancing financial and operational performance in the healthcare sector.
Potential Negatives
- CareCloud's reliance on acquisitions for growth may raise concerns about the sustainability of its business model, as it suggests a potential lack of organic growth.
- The acknowledgment of risks related to managing growth and customer retention indicates potential instability in maintaining relationships, which could impact future revenue.
- The heavy emphasis on AI-driven improvements and the substantial claim denial reduction may imply past issues with claim management, suggesting operational vulnerabilities that need addressing.
FAQ
What is CareCloud's main strategy for growth?
CareCloud focuses on acquisitions, AI innovation, and cross-selling existing customer relationships to create recurring revenue opportunities.
How has CareCloud improved its operational performance?
Through AI and automation, CareCloud has reduced claim denials by over 40% in the past year, enhancing efficiency.
What types of agreements has CareCloud announced?
CareCloud has secured multiple full-service RCM agreements, highlighting the success of its cross-selling strategy with existing customers.
Who are some of CareCloud's new RCM clients?
New clients include Davis Orthopedics in Alabama, a behavioral health group in Rhode Island, and a medical practice in New York.
What services does CareCloud offer its customers?
CareCloud provides solutions in revenue cycle management, practice management, electronic health records, patient experience management, and digital health.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CCLD Revenue
$CCLD had revenues of $33.7M in Q3 2026. This is an increase of 8.56% from the same period in the prior year.
You can track CCLD financials on Quiver Quantitative's CCLD stock page.
You can access data on CCLD stock through the Quiver Quantitative API.
$CCLD Hedge Fund Activity
We have seen 24 institutional investors add shares of $CCLD stock to their portfolio, and 42 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ESSEX INVESTMENT MANAGEMENT CO LLC removed 697,836 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,479,412
- MARSHALL WACE, LLP removed 373,731 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $792,309
- MILLENNIUM MANAGEMENT LLC removed 230,534 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $488,732
- SEI INVESTMENTS CO removed 228,358 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $484,118
- ROUND ROCK ADVISORS LLC removed 216,388 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $458,742
- AMERIPRISE FINANCIAL INC removed 212,381 shares (-48.1%) from their portfolio in Q3 2026, for an estimated $433,257
- 683 CAPITAL MANAGEMENT, LLC removed 159,761 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $338,693
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
New RCM relationships demonstrate CareCloud’s strategy to convert acquisitions, AI innovation and existing customer relationships into recurring revenue opportunities.
SOMERSET, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management (RCM) solutions, today announced multiple new full-service RCM agreements, highlighting the success of its acquisition-driven cross-selling strategy. Through AI and automation, CareCloud has reduced claim denials by over 40% in the past year, demonstrating improved operational performance and strengthening its ability to expand customer relationships.
“Our strategy is straightforward: acquisitions expand our customer base, AI improves performance, and cross-selling creates opportunities for recurring revenue growth,” said Stephen Snyder, Chief Executive Officer of CareCloud. “These new agreements demonstrate how we can generate additional business from existing relationships while building a more scalable, technology-enabled operating model. We believe this approach can accelerate organic growth and create long-term shareholder value.”
New RCM Wins Demonstrate Cross-Selling Success
Three existing SaaS customers–Davis Orthopedics in Alabama, a behavioral health group in Rhode Island, and an independent medical practice in New York–have expanded their CareCloud relationships to include full-service RCM.
“Turnover on our practice’s internal billing team caused our days in A/R to spike, and it showed us how exposed a small practice like ours is when collections depend on just a few people,” said Matthew Davis, M.D., of Davis Orthopedics. “Expanding our partnership to include CareCloud’s revenue cycle services gives us a full team backed by AI-driven results, with fewer denials and a revenue cycle that keeps running consistently, which protects the practice financially and lets us stay focused on patient care.”
These new relationships build on the four previously announced RCM agreements–with a management services organization and multiple wound care practices–CareCloud signed during the fourth quarter through Empower, the healthcare compliance and advisory firm the Company acquired in May 2026. These wins illustrate how acquired advisory relationships can create additional revenue opportunities across CareCloud’s broader portfolio.
Building a Scalable Organic Growth Engine
CareCloud’s strategy combines acquisitions, AI-driven operational improvements and cross-selling to increase revenue opportunities within its existing customer base.
With more than 40,000 providers relying on its solutions and services, CareCloud believes it has significant opportunities to expand adoption of RCM, AI-powered automation, credentialing, practice management and digital health solutions.
The Company intends to continue leveraging its established customer relationships and AI capabilities to pursue recurring revenue growth, operational efficiencies and long-term shareholder value.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. The Company’s suite of AI and technology-enabled solutions helps healthcare organizations increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers rely on CareCloud’s solutions and services across revenue cycle management, practice management, electronic health records, patient experience management, business intelligence and digital health.
Follow CareCloud on LinkedIn , X and Facebook .
For additional information, please visit our website at carecloud.com . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com .
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Bonnie Boyer
Chief Financial Officer
CareCloud, Inc.
[email protected]
Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
[email protected]